Abstract
High performance liquid chromatography (HPLC) is a powerful tool to measure neurotransmitter levels in specific tissue samples and dialysates from patients and animals. In this chapter, we list the current protocols used to measure neurotransmitters in the form of biogenic amines from murine brain samples.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pujol J, Junque C, Vendrell P, Grau JM, Capdevila A (1992) Reduction of the substantia nigra width and motor decline in aging and Parkinson’s disease. Arch Neurol 49(11):1119–1122
Hansen FH, Skjorringe T, Yasmeen S, Arends NV, Sahai MA, Erreger K et al (2014) Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. J Clin Invest 124(7):3107–3120
Kristensen AS, Andersen J, Jorgensen TN, Sorensen L, Eriksen J, Loland CJ et al (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63(3):585–640
Brines ML, Robbins RJ (1993) Cell-type specific expression of Na+, K(+)-ATPase catalytic subunits in cultured neurons and glia: evidence for polarized distribution in neurons. Brain Res 631(1):1–11
Cameron R, Klein L, Shyjan AW, Rakic P, Levenson R (1994) Neurons and astroglia express distinct subsets of Na, K-ATPase alpha and beta subunits. Brain Res Mol Brain Res 21(3-4):333–343
McGrail KM, Phillips JM, Sweadner KJ (1991) Immunofluorescent localization of three Na, K-ATPase isozymes in the rat central nervous system: both neurons and glia can express more than one Na, K-ATPase. J Neurosci 11(2):381–391
Kleene R, Loers G, Langer J, Frobert Y, Buck F, Schachner M (2007) Prion protein regulates glutamate-dependent lactate transport of astrocytes. J Neurosci 27(45):12331–12340
Brashear A, Butler IJ, Hyland K, Farlow MR, Dobyns WB (1998) Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism. Ann Neurol 43(4):521–526
de Carvalho AP, Sweadner KJ, Penniston JT, Zaremba J, Liu L, Caton M et al (2004) Mutations in the Na+/K+-ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 43:169–175
Rosewich H, Thiele H, Ohlenbusch A, Maschke U, Altmuller J, Frommolt P et al (2012) Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study. Lancet Neurol 11(9):764–773
Heinzen EL, Swoboda KJ, Hitomi Y, Gurrieri F, Nicole S, de Vries B et al (2012) De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet 44(9):1030–1034
Demos MK, van Karnebeek CD, Ross CJ, Adam S, Shen Y, Zhan SH et al (2014) A novel recurrent mutation in ATP1A3 causes CAPOS syndrome. Orphanet J Rare Dis 9:15
De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L et al (2003) Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33(2):192–196
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Holm, T.H., Isaksen, T.J., Lykke-Hartmann, K. (2016). HPLC Neurotransmitter Analysis. In: Bublitz, M. (eds) P-Type ATPases. Methods in Molecular Biology, vol 1377. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3179-8_29
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3179-8_29
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3178-1
Online ISBN: 978-1-4939-3179-8
eBook Packages: Springer Protocols